Pfizer projects 2025 revenue growth up to $64 billion
Pfizer forecasts 2025 revenue of up to $64 billion and adjusted earnings growth, navigating cost challenges amid Medicare changes and advancing promising drug pipeline assets,...
Tag : oncology
Merck and Daiichi Sankyo forge $5.5 billion cancer drug alliance
Merck, a global pharmaceutical giant, has inked a partnership with Japanese firm Daiichi Sankyo, valuing at $5.5 billion, to co-develop three advanced cancer therapies. Depending...